Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation
Background and Purpose—There are limited real-world data comparing the effectiveness
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …
Outcomes after use of standard-and low-dose non–vitamin k oral anticoagulants in Asian patients with atrial fibrillation
MS Cho, JE Yun, JJ Park, YJ Kim, J Lee, H Kim… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Limited data are available describing the relative effectiveness,
safety, and optimal dosing of non–vitamin K antagonist oral anticoagulants (NOACs) for …
safety, and optimal dosing of non–vitamin K antagonist oral anticoagulants (NOACs) for …
Effectiveness and safety of contemporary oral anticoagulants among Asians with nonvalvular atrial fibrillation
Background and Purpose—Limited evidence exists on the effectiveness and safety of
warfarin and all 4 available non-vitamin K antagonist oral anticoagulants (NOACs) from …
warfarin and all 4 available non-vitamin K antagonist oral anticoagulants (NOACs) from …
The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared …
Background Although randomized trials provide a high level of evidence regarding the
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project
Background Little is known about the comparative effectiveness and safety of non–vitamin K
antagonist oral anticoagulants (NOAC) compared to warfarin in Chinese atrial fibrillation …
antagonist oral anticoagulants (NOAC) compared to warfarin in Chinese atrial fibrillation …
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal
GYH Lip, KL Wang, CE Chiang - International journal of cardiology, 2015 - Elsevier
Non-vitamin K antagonist oral anticoagulants (NOACs) have changed the landscape for
stroke prevention in atrial fibrillation (AF). Given the huge burden of AF in Asians, more …
stroke prevention in atrial fibrillation (AF). Given the huge burden of AF in Asians, more …
Efficacy and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation–meta-analysis–
Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have been developed as
alternatives to warfarin. Until recently, the latter was the standard oral anticoagulant for …
alternatives to warfarin. Until recently, the latter was the standard oral anticoagulant for …
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies
Z Xue, H Zhang - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Several randomized trials and real-world studies have reported
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
Non–vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis
KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
Effectiveness and safety of standard-dose nonvitamin K antagonist oral anticoagulants and warfarin among patients with atrial fibrillation with a single stroke risk factor …
Importance The randomized clinical trials comparing nonvitamin K antagonist oral
anticoagulants (NOACs) vs warfarin largely focused on recruiting high-risk patients with …
anticoagulants (NOACs) vs warfarin largely focused on recruiting high-risk patients with …